<?xml version="1.0" encoding="UTF-8"?>
<p>Some studies have highlighted the impact of CCA on daily activities and quality of life [
 <xref rid="pntd.0007327.ref035" ref-type="bibr">35</xref>–
 <xref rid="pntd.0007327.ref038" ref-type="bibr">38</xref>,
 <xref rid="pntd.0007327.ref041" ref-type="bibr">41</xref>]. Patients suffering from CCA have been shown to require a multidisciplinary medical care program [
 <xref rid="pntd.0007327.ref078" ref-type="bibr">78</xref>,
 <xref rid="pntd.0007327.ref079" ref-type="bibr">79</xref>]. One study recommends long-term follow up by a general practitioner, often in cooperation with a rheumatologist or a rehabilitation physician [
 <xref rid="pntd.0007327.ref080" ref-type="bibr">80</xref>]. Chikungunya disease and especially CCA with relapsing sequela have been shown to induce anxiety, stress, and even a nervous breakdown [
 <xref rid="pntd.0007327.ref081" ref-type="bibr">81</xref>,
 <xref rid="pntd.0007327.ref082" ref-type="bibr">82</xref>]. Medical treatments include analgesics, anti-inflammatory drugs, corticosteroids, and in severe cases anticonvulsant and immunosuppressive therapy [
 <xref rid="pntd.0007327.ref079" ref-type="bibr">79</xref>,
 <xref rid="pntd.0007327.ref083" ref-type="bibr">83</xref>,
 <xref rid="pntd.0007327.ref084" ref-type="bibr">84</xref>]. Moreover, treatment may be combined with physiotherapy, physical therapy, and psychiatric and psychological evaluation [
 <xref rid="pntd.0007327.ref081" ref-type="bibr">81</xref>,
 <xref rid="pntd.0007327.ref082" ref-type="bibr">82</xref>–
 <xref rid="pntd.0007327.ref085" ref-type="bibr">85</xref>]. Long-term disabilities caused by chikungunya are costly at the individual and collective scales. The economic impact of the 2005–2006 chikungunya outbreak in Reunion Island was estimated at 51.63 million US dollars [
 <xref rid="pntd.0007327.ref086" ref-type="bibr">86</xref>].
</p>
